Background: Dextromethorphan (DM), the d-isomer of the codeine analog levorphanol, is an active ingredient present in a variety of cough and cold remedies. Recently, data generated from a study in ...

Continued treatment with AXS-05, a combination of dextromethorphan and bupropion, significantly reduces the risk for recurrence of Alzheimer’s disease–related agitation, phase 3 results show.

Anyone in the U.S. who bought any flavor Robitussin product containing dextromethorphan (or DXM) and labeled as “non-drowsy” between Feb. 16, 2016, and Jan. 21 are eligible to file a claim, according ...

India's drug regulator has banned the manufacture and sale of 35 fixed dose combinations (FDCs), citing concerns over patient ...

Axsome Therapeutics, Inc.’s AXSM share price has dipped by 8.23%, which has investors questioning if this is right time to ...

While humans have used opioids for their medicinal benefits, the drug has paved the path of both treatment and tragedy.

Agitated patients are often prescribed antipsychotic medications and sedatives off-label, but this can pose a risk to the ...

At the recent American Academy of Neurology (AAN) 2025 annual meeting, Axsome Therapeutics (Nasdaq: AXSM) presented promising data for AXS-05 (bupropion + dextromethorphan) in treating agitation ...

CDSCO asks States and UTs to act upon list of 35 FDCs declared as new drugs: Gireesh Babu, New Delhi Wednesday, April 16, 2025, 08:00 Hrs [IST] The Drugs Controller General of Ind ...

Consumers who bought a popular cough syrup could be eligible for money as part of a class action settlement. Robitussin maker Haleon has agreed to pay $4.5 million to resolve claims it advertised the ...

The Central Drugs Standard Control Organisation (CDSCO) has issued a stern directive to all State and Union Territory Drug ...

A complaint filed in June 2022 said calling those products non-drowsy is “false and misleading,” arguing that Robitussin contains dextromethorphan, a cough suppressant commonly found in over ...